Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site

This study has been terminated.
(recruitment goals met)
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by:
University of Michigan Cancer Center
ClinicalTrials.gov Identifier:
NCT00148135
First received: September 2, 2005
Last updated: December 28, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2007
  Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)